Advertisement · 728 × 90
#
Hashtag
#T2D
Advertisement · 728 × 90
Preview
Diabetes and mental health This Review summarises the research into five common mental health problems that can affect adults living with type 1 diabetes, type 2 diabetes, or gestational diabetes: fear of hypoglycaemia, diabete...

Mental health problems can impair self-care behaviours and contribute to the development of some types of #diabetes and diabetes complications www.thelancet.com/journals/lan...
#MentalHealth #T1D #T2D #GDM

#MedSky #EndoSky #PsychSky

2 0 0 0
Post image

Every form of type 2 #diabetes begins, & ultimately converges, within the biology of the #islet. When that convergence is complete, the story of diabetes will no longer be a dissonance but an islet harmony that connects mechanism to meaning www.thelancet.com/journals/lan... #T2D

#MedSky #EndoSky

1 0 0 0

📊 New findings: In 8% of people newly diagnosed with type 2 diabetes #T2D, low blood sugar occurs 3 hours after the #OGTT. Post‑OGTT hypoglycemia is associated with higher insulin sensitivity. All cases fell into the Ahlqvist clusters mild obesity‑related or age‑related diabetes.
➡️ rdcu.be/fbkFp

2 0 0 0
Preview
Glu Sight | Track glucose and insulin on iPhone. Log glucose and insulin fast, spot patterns sooner, and walk into appointments with clear reports. A privacy-first diabetes app for iPhone.

Your glucose data has been trying to tell you something.

Glu Sight finally translates it.

📲 about.glusight.app

#Diabetes #T1D #T2D​​​​​​​​​​​​​​​​

0 0 0 0
Post image

Both adherence to a #healthy #lifestyle and #GLP-1 receptor agonist use are independently associated with low risk of #MACE among veterans with type 2 #diabetes, and their combination is associated with a greater risk reduction than either approach alone
www.thelancet.com/journals/lan...
#T2D #CVD

0 0 0 0
Post image Post image Post image

🎬I have built a small library of concise YouTube videos for people living with #T2D discussing:

🎯Positive lifestyle choices & #T2D
🎯Various aspects of #SGLT2i use including benefits, side-effects & sick day guidance
🎯UACR & #T2D with @kidneyresearchuk.org

Link in comments⬇️
@pharmrj.pharmsky.app

1 1 1 0
Post image

While waiting for FOCUS, analysis of a matched real world TriNetX cohort of 350,536 patients with #T2D and #CVD followed for up to 5 years revealed reduced rates of legal blindness pubmed.ncbi.nlm.nih.gov/41907810/

3 0 0 1
The Lancet Summit: shaping the future of diabetes prevention.  Image credit: Ixefra / Getty Images

The Lancet Summit: shaping the future of diabetes prevention. Image credit: Ixefra / Getty Images

📣 Preliminary programme announced!

15 renowned academic and lived experience experts will lead an exceptional programme highlighting lessons learned in preventing #diabetes

View the programme and submit your abstracts by Jun 12: hubs.li/Q03MV4_x0

#T1D #T2D #ADASciSessions

1 1 0 0
Post image

💊#FDA Approval Update | #Awiqli (#insulin icodec), the first once-weekly basal insulin approved for #T2D
💉365→52 injections/year
📊To improve long-term glycemic control
🧪We offer insulin icodec for research use only: www.medchemexpress.com/insulin-icod...
www.medchemexpress.com/disease-area...

0 0 0 0
Preview
Beyond the heart: the urgent need for a dementia-forward diabetes agenda The clinical practice of diabetes management has undergone a paradigm shift over the past two decades. GLP-1 receptor agonists and SGLT2 inhibitors have expanded the therapeutic focus beyond glycaemic...

Linked Comment:
Beyond the #heart: the urgent need for a #dementia-forward #diabetes agenda www.thelancet.com/journals/lan...
#T2D #CVD

#MedSky #EndoSky

0 0 0 0
Post image

Mortality from #cardiovascular disease and #diabetes has declined among people with diabetes in most jurisdictions, whereas mortality from #dementia has increased markedly, independent of age www.thelancet.com/journals/lan...
#T2D #CVD

#MedSky #EndoSky

1 0 1 0
Preview
Risk factors identified for progression to diabetes Curated by <b>Smartbrief</b>. Adults ages 35 to 64 with prediabetes are more likely than younger adults to develop type 2 diabetes. Comorbidities such as obesity, cardiovascular disease and sleep apne...

En pac c/prediabetes, edad entre 35 a 64 a, obesidad, enf CV, apnea obstructiva del sueño, esteatohepatitis asoc a disfunción metabólica y neuropatía el año antes de la progresión, se asocian con progresión a diabetes tipo 2 #T2D #prediabetes #Progression newsletter.smartbrief.com/sharedSummar...

0 0 0 0
This image is an infographic detailing a study by Houston Methodist CV Learning Health System (2016-2023). It explores the relationship between social determinants of health (SDoH) and new-onset type 2 diabetes risk. The study found that aggregated SDoH burden strongly predicts new-onset T2DM, indicating that addressing SDoH can help reduce diabetes risk. The infographic includes sections labeled "Background," "Methods," "Results," and "Conclusions," with visual elements and data such as a hazard ratio of 1.95 and an inverse relationship graph between SDoH burden and T2DM risk.

This image is an infographic detailing a study by Houston Methodist CV Learning Health System (2016-2023). It explores the relationship between social determinants of health (SDoH) and new-onset type 2 diabetes risk. The study found that aggregated SDoH burden strongly predicts new-onset T2DM, indicating that addressing SDoH can help reduce diabetes risk. The infographic includes sections labeled "Background," "Methods," "Results," and "Conclusions," with visual elements and data such as a hazard ratio of 1.95 and an inverse relationship graph between SDoH burden and T2DM risk.

SDoH are robust, independent predictors of #T2D. Proactive incorporation of SDoH data into patient care could optimize social interventions to prevent T2DM risk and reduce health disparities. #DOCM

Read here ➡️ doi.org/10.2337/doc25-0006

1 0 0 0
Preview
GLP-1 drugs may improve survival of people with brain metastases People with cancer brain metastases and type 2 diabetes might derive a survival benefit from the use of glucagon-like peptide-1 receptor agonists.

#MedNews - People with cancer brain metastases and #T2D might derive a survival benefit from the use of #GLP1 receptor agonists.

Full story 👉 buff.ly/xtsSB6c

#OncSky

1 0 0 0
Preview
Liver stiffness measurement independently predicts mortality risk in type 2 diabetes Liver stiffness measurement is an independent risk factor for overall mortality in people with type 2 diabetes, even over just 2 years of follow-up.

#MedNews - Liver stiffness measurement is an independent risk factor for overall mortality in people with #Type2Diabetes, even over just 2 years of follow-up.

Full story 👉 buff.ly/QOLSRNp

#T2D #Diabetes

0 0 0 0
Two smartphones displaying diabetes management apps against a teal background. The larger phone shows "Today" with a glucose average of 118 mg/dL and total insulin of 12.5 units, along with alerts for high glucose and insulin usage. The smaller phone displays a glucose pattern analysis, indicating frequent high readings between 12pm and 2pm, with 263 records, 1 insulin injection, and 6 very high events. Both phones have navigation icons at the bottom.

Two smartphones displaying diabetes management apps against a teal background. The larger phone shows "Today" with a glucose average of 118 mg/dL and total insulin of 12.5 units, along with alerts for high glucose and insulin usage. The smaller phone displays a glucose pattern analysis, indicating frequent high readings between 12pm and 2pm, with 263 records, 1 insulin injection, and 6 very high events. Both phones have navigation icons at the bottom.

I built a diabetes management app: everything for today, in one place.

Average glucose, time in range, insulin, and trends, without switching screens.

#diabetes #t2d #t1d #ios #indiedev #buildinpublic

9 2 1 0
Preview
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and feasibility of remission warrant closer examination. Type 2 diabetes remissio...

By re-evaluating current definitions, acknowledging the progressive nature of type 2 #diabetes, and embracing individualised approaches to glycaemic control, #remission can be redefined as a dynamic continuum rather than a static endpoint www.thelancet.com/journals/lan... #T2D

#MedSky #EndoSky

0 0 0 0

Not even sure what I want to post. So many thoughts running through my mind. Getting older, not looking after myself. Ignoring my Type 2 diabetes. Not exercising or eating right. Feeling alone in my marriage. Just a little venting.
#menshealth #mentalhealth #T2D #menover60

2 0 0 0
Video

Don’t guess.

Have your glucose readings been in range today?

One tap shows your target range and today’s highs and lows.

#diabetes #t2d #t1d #ios #indiedev #buildinpublic

4 1 1 0
Figure 1. Left: incremental glucose concentrations and corresponding iAUCs. Right: triglyceride concentrations and corresponding iAUCs. Blood samples were collected from 30 minutes before to 3 hours after the meal (time point 0). *p<0.05, ***p<0.001.

Figure 1. Left: incremental glucose concentrations and corresponding iAUCs. Right: triglyceride concentrations and corresponding iAUCs. Blood samples were collected from 30 minutes before to 3 hours after the meal (time point 0). *p<0.05, ***p<0.001.

⭐️ Exogenous ketones may reduce postprandial glucose, lipids and ghrelin in individuals with #T2D, a @diabetologiajnl.bsky.social publication suggests. However, they should currently be regarded as an experimental metabolic strategy, emphasises Nikolaj Rittig.

🔗👉 easd-elearning.eu/news/466/Ket...

5 2 0 0
Post image

In the past three decades, there has been growing recognition of the complex interplay between mental health and physical health among people with #diabetes www.thelancet.com/journals/lan...
#T1D #T2D #GDM #mentalhealth

#MedSky #EndoSky #PsychSky

7 3 0 1
Video

Glu Sight update:

• insulin reminders now show how late a dose is (Lock Screen / Dynamic Island)
• clearer progress + cleaner layout
• guided Apple Health setup
• improved localization

Update available now.

#diabetes #t2d #insulin #health

1 0 0 0
Preview
How to succeed? Get more sleep In this short talk, Arianna Huffington shares a small idea that can awaken much bigger ones: the power of a good night's sleep. Instead of bragging about our sleep deficits, she urges us to shut our eyes and see the big picture: We can sleep our way to increased productivity and happiness -- and smarter decision-making.

An oldie but a goodie. The older I get, the more aware I am of the importance of work-life balance, nutrition, hydration, and mental and physical rest. My recent diabetes diagnosis has brought this into even sharper focus.

www.ted.com/talks/ariann...

#WorkLifeBalance #T2D #T1D #Diabetes #Wellbeing

2 0 1 0
This image is an infographic summarizing research findings on the risk of NAION with GLP-1 RAs compared to DPP-4 inhibitors. It includes sections on study design, exposure groups, statistical analysis, and a table with follow-up times showing risk differences and ratios with confidence intervals. The data source is cited as the CPRD, Clinical Practice Research Datalink.

This image is an infographic summarizing research findings on the risk of NAION with GLP-1 RAs compared to DPP-4 inhibitors. It includes sections on study design, exposure groups, statistical analysis, and a table with follow-up times showing risk differences and ratios with confidence intervals. The data source is cited as the CPRD, Clinical Practice Research Datalink.

Initiation of #GLP-1 receptor agonists, most notably semaglutide, is associated with an increased one-year risk of NAION compared with DPP-4 inhibitors in adults with #T2D.
@PROFLAZOULAY

Read here ➡️ doi.org/10.2337/dc25-2577

1 0 0 0
EFSD Recipient Research Portrait graphic featuring Doctor Joan-Marc Servitja from the Clinic Barcelona Research Foundation - August Pi i Sunyer Biomedical Research Institute, Spain. A circular headshot shows a man with dark hair and a beard wearing a white lab coat. The background uses a bold blue, teal, and green geometric design. The EFSD (European Foundation for the Study of Diabetes) logo appears at the bottom.

EFSD Recipient Research Portrait graphic featuring Doctor Joan-Marc Servitja from the Clinic Barcelona Research Foundation - August Pi i Sunyer Biomedical Research Institute, Spain. A circular headshot shows a man with dark hair and a beard wearing a white lab coat. The background uses a bold blue, teal, and green geometric design. The EFSD (European Foundation for the Study of Diabetes) logo appears at the bottom.

EFSD research graphic with the title 'Effects of circulating extracellular vesicles on pancreatic islets during obesity.' A text block on a green background describes Joan-Marc Servitja's research into how circulating extracellular vesicles and their small RNA cargo regulate pancreatic beta-cell adaptation and failure during obesity, with the aim of identifying new therapeutic targets for type 2 diabetes. The EFSD logo appears at the bottom left on a light blue background with decorative curved design elements.

EFSD research graphic with the title 'Effects of circulating extracellular vesicles on pancreatic islets during obesity.' A text block on a green background describes Joan-Marc Servitja's research into how circulating extracellular vesicles and their small RNA cargo regulate pancreatic beta-cell adaptation and failure during obesity, with the aim of identifying new therapeutic targets for type 2 diabetes. The EFSD logo appears at the bottom left on a light blue background with decorative curved design elements.

EFSD promotional graphic stating the research is supported by the EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes.' The lower half features a dark navy box with bold white text reading 'Apply for research grants and fellowships' and the website europeandiabetesfoundation.org. The light blue background includes decorative curved lines in navy and teal.

EFSD promotional graphic stating the research is supported by the EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes.' The lower half features a dark navy box with bold white text reading 'Apply for research grants and fellowships' and the website europeandiabetesfoundation.org. The light blue background includes decorative curved lines in navy and teal.

🧠Meet Joan-Marc Servitja ( @idibaps.bsky.social), #EFSD/@boehringerglobal.bsky.social "Multi-System Challenges in #Diabetes" recipient studying how EVs affect beta-cells in #obesity, shifting from protective to harmful & revealing sex-specific #T2D effects.

📖 journals.physiology.org/doi/full/10....

2 1 0 0
Post image

People with #MASLD can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 #diabetes, #cardiovascular disease, chronic #kidney disease, and extrahepatic cancers www.thelancet.com/journals/lan...
#T2D #CVD #CKD
#OpenAccess

#MedSky #EndoSky #LiverSky

6 1 3 0
Preview
4-drug regimen studied for type 2 diabetes management Curated by <b>Smartbrief</b>. A study in South Korea found that adding a fourth oral antidiabetic drug to a triple regimen provided better glycemic control than increasing the dose of metformin in pat...

Terapia antidiabética cuádruple mejora glucemia y metabolismo sin comprometer seguridad, vs ajuste de metformina en pac con diabetes tipo 2 no adecuadamente controlada, por lo que tiene un papel como estrategia de intensificación #T2D #intensification: newsletter.smartbrief.com/sharedSummar...

0 0 0 0
Post image

🚨 EXTENDED 2ND ROUND ABSTRACT SUBMISSION CLOSING IN 24 HOURS!

🧬 Diet–Microbiome interactions play a crucial role in Type 2 Diabetes—from BCAAs & inflammation to SCFAs and insulin sensitivity.

📍 GMC 2026 | June 15–16 | Boston, USA
👉: microbiomecongress.org/abstract-sub...

#T2D #GutHealth

0 0 0 0

Off for my first eye screening tomorrow. Not worried, but a bit nervous… #T2D #Type2Diabetes #Diabetes

3 0 0 0
Preview
Weight loss independent outcomes in type 2 diabetes mellitus and other metabolic comorbidities after Roux-en-Y gastric bypass and sleeve gastrectomy - International Journal of Obesity International Journal of Obesity - Weight loss independent outcomes in type 2 diabetes mellitus and other metabolic comorbidities after Roux-en-Y gastric bypass and sleeve gastrectomy

Scrutiny of #weightloss independent outcomes after metabolic surgery in PPL with #T2D www.nature.com/articles/s41...

0 0 0 0